Paper Details
- Home
- Paper Details
Amoxapine as an atypical antipsychotic: a comparative study vs risperidone.
Author: ApiquianRogelio, FresanAna, Herrera-EstrellaMiguel, KapurShitij, NicoliniHumberto, UlloaRosa-Elena, VazquezAlejandra, de la Fuente-SandovalCamilo
Original Abstract of the Article :
Amoxapine is marketed as an antidepressant. However, its in-vitro profile, receptor occupancy and preclinical effects are very similar to atypical antipsychotics. Amoxapine has also shown efficacy as an atypical antipsychotic in open trials. The objective of this study was to compare the antipsychot...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1038/sj.npp.1300796
データ提供:米国国立医学図書館(NLM)
Amoxapine: A New Oasis in the Desert of Schizophrenia Treatment
The world of schizophrenia treatment is a vast desert, where patients often struggle to find effective and well-tolerated medications. This study compares the antipsychotic and side effect profile of amoxapine, a medication typically used for depression, and risperidone, a commonly used antipsychotic. It's like comparing two different oases, each offering a unique approach to navigating the challenges of this complex condition. The researchers found that amoxapine was as effective as risperidone in improving symptoms of schizophrenia, but it was associated with fewer extrapyramidal symptoms (EPS) and lower prolactin levels. This suggests that amoxapine might be a valuable alternative to newer antipsychotics, especially in resource-limited settings. This is like discovering a new and accessible oasis that offers similar benefits to established ones.
Amoxapine: A Promising Alternative for Schizophrenia Treatment
This study suggests that amoxapine, a readily available medication, may be a viable alternative for treating schizophrenia, particularly in resource-constrained environments. This is like finding a new source of water in the desert, offering a more affordable and potentially safer option. The researchers encourage clinicians to consider amoxapine as a treatment option for schizophrenia, especially in settings where newer antipsychotics are less accessible.
Navigating the Desert of Schizophrenia Treatment
Schizophrenia is a complex and challenging condition that requires careful management. This study highlights the importance of exploring different treatment options, considering both efficacy and tolerability. It's like navigating the vast desert of schizophrenia treatment, seeking the best path to improve the lives of patients. The authors emphasize the need for ongoing research to develop new and improved treatments for schizophrenia, ensuring that patients have access to the best possible care.
Dr.Camel's Conclusion
This study explores the potential of amoxapine as a valuable treatment option for schizophrenia, offering a promising alternative to newer antipsychotics. It's like discovering a hidden oasis in the desert, offering relief from the challenging symptoms of this complex condition. The researchers encourage the use of amoxapine as a potential treatment option, particularly in resource-limited settings.
Date :
- Date Completed 2006-01-24
- Date Revised 2015-03-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.